EXHIBIT 8.1 | ||||||
Principal Subsidiaries | ||||||
At 31 December 2006 | Country | Percentage of voting share capital held | Principal activity | |||
UK | ||||||
AstraZeneca UK Limited | England | 1001 | Research and development, manufacturing, marketing | |||
AstraZeneca Reinsurance Limited | England | 100 | Insurance and reinsurance underwriting | |||
AstraZeneca Treasury Limited | England | 100 | Treasury | |||
Continental Europe | ||||||
NV AstraZeneca SA | Belgium | 100 | Manufacturing, marketing | |||
AstraZeneca Dunkerque Production SCS | France | 100 | Manufacturing | |||
AstraZeneca SAS | France | 100 | Research, manufacturing, marketing | |||
AstraZeneca GmbH | Germany | 100 | Development, manufacturing, marketing | |||
AstraZeneca Holding GmbH | Germany | 100 | Manufacturing, marketing | |||
AstraZeneca SpA | Italy | 100 | Manufacturing, marketing | |||
AstraZeneca Farmaceutica Spain SA | Spain | 100 | Manufacturing, marketing | |||
AstraZeneca AB | Sweden | 100 | Research and development, manufacturing, marketing | |||
AstraZeneca BV | The Netherlands | 100 | Marketing | |||
The Americas | ||||||
AstraZeneca Canada Inc. | Canada | 100 | Research, manufacturing, marketing | |||
IPR Pharmaceuticals Inc. | Puerto Rico | 100 | Development, manufacturing, marketing | |||
AstraZeneca LP | US | 99 | Research and development, manufacturing, marketing | |||
AstraZeneca Pharmaceuticals LP | US | 100 | Research and development, manufacturing, marketing | |||
Zeneca Holdings Inc. | US | 100 | Manufacturing, marketing | |||
Asia, Africa & Australasia | ||||||
AstraZeneca Pty Limited | Australia | 100 | Development, manufacturing, marketing | |||
AstraZeneca KK | Japan | 80 | Manufacturing, marketing |
- AZN Dashboard
- Financials
- Filings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
- News
-
20-F Filing
Astrazeneca (AZN) 20-F2006 FY Annual report (foreign)
Filed: 27 Mar 07, 12:00am